EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ansell's enterprise value is $2,658 Mil.
Ansell's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $226 Mil. Therefore, Ansell's EV-to-EBITDA for today is 11.79.
The historical rank and industry rank for Ansell's EV-to-EBITDA or its related term are showing as below:
ANSLF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6 Med: 12.81 Max: 34.49
Current: 12.04
During the past 13 years, the highest EV-to-EBITDA of Ansell was 34.49. The lowest was 6.00. And the median was 12.81.
ANSLF's EV-to-EBITDA is ranked better than 60.12% of 484
companies
in the Medical Devices & Instruments industry
Industry Median: 16.065
vs ANSLF: 12.04
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-05), Ansell's stock price is $15.05.
Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.818. Therefore, Ansell's PE Ratio for today is 18.40.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Ansell EV-to-EBITDA Historical Data
The historical data trend for Ansell's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ansell's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ansell's EV-to-EBITDA falls into.
Ansell's current Enterprise Value is $2,658 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $226 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ansell (OTCPK:ANSLF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ansell's share price for today is $15.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.818.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Ansell's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANSLF has been successfully added to your 